Evoke Pharma Inc Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2016 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Evoke Pharma Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2016 to Q3 2024.
- Evoke Pharma Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.4M shares, a 403% increase year-over-year.
- Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 3.34M shares, a 6.34% increase from 2022.
- Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.14M shares, a 17.2% increase from 2021.
- Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 2.68M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)